These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 4341481

  • 1. Inhibition of the conversion of angiotensin I to II and potentiation of bradykinin by small peptides present in Bothrops jararaca venom.
    Greene LJ, Camargo AC, Krieger EM, Stewart JM, Ferreira SH.
    Circ Res; 1972 Sep; 31(9):Suppl 2:62-71. PubMed ID: 4341481
    [No Abstract] [Full Text] [Related]

  • 2. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
    Ianzer D, Santos RA, Etelvino GM, Xavier CH, de Almeida Santos J, Mendes EP, Machado LT, Prezoto BC, Dive V, de Camargo AC.
    J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
    [Abstract] [Full Text] [Related]

  • 3. Biologically active peptides from Bothrops jararacussu venom.
    Ferreira LA, Henriques OB, Lebrun I, Batista MB, Prezoto BC, Andreoni AS, Zelnik R, Habermehl G.
    Agents Actions Suppl; 1992 Aug; 36():209-14. PubMed ID: 1609644
    [Abstract] [Full Text] [Related]

  • 4. Potentiation of bradykinin and eledoisin by BPF (bradykinin potentiating factor) from Bothrops jararaca venom.
    Ferreira SH, Rocha e Silva M.
    Experientia; 1965 Jun 15; 21(6):347-9. PubMed ID: 5870517
    [No Abstract] [Full Text] [Related]

  • 5. Bradykinin potentiating peptide PCA-Lys-Trp-Ala-Pro. An inhibitor of the pulmonary inactivation of bradykinin and conversion of angiotensin I to II.
    Stewart JM, Ferreira SH, Greene LJ.
    Biochem Pharmacol; 1971 Jul 15; 20(7):1557-67. PubMed ID: 4355304
    [No Abstract] [Full Text] [Related]

  • 6. Converting enzyme and bradykininase in the lung.
    Alabaster VA, Bakhle YS.
    Circ Res; 1972 Sep 15; 31(9):Suppl 2:72-84. PubMed ID: 4341482
    [No Abstract] [Full Text] [Related]

  • 7. Bradykinin potentiating factor.
    Greene LJ, Ferreira SH, Stewart JM.
    Chest; 1971 May 15; 59():Suppl:9S-10S. PubMed ID: 4325034
    [No Abstract] [Full Text] [Related]

  • 8. Isolation and characterization of a novel bradykinin potentiating peptide (BPP) from the skin secretion of Phyllomedusa hypochondrialis.
    Conceição K, Konno K, de Melo RL, Antoniazzi MM, Jared C, Sciani JM, Conceição IM, Prezoto BC, de Camargo AC, Pimenta DC.
    Peptides; 2007 Mar 15; 28(3):515-23. PubMed ID: 17098329
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of angiotensin I converting enzyme by venom peptides.
    Bakhle YS.
    Br J Pharmacol; 1971 Sep 15; 43(1):252-4. PubMed ID: 4332776
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of angiotensin converting enzyme and potentiation of bradykinin by retro-inverso analogues of short peptides and sequences related to angiotensin I and bradykinin.
    Carmona AK, Juliano L.
    Biochem Pharmacol; 1996 Apr 26; 51(8):1051-60. PubMed ID: 8866827
    [Abstract] [Full Text] [Related]

  • 11. Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom.
    Ferreira SH, Bartelt DC, Greene LJ.
    Biochemistry; 1970 Jun 23; 9(13):2583-93. PubMed ID: 4317874
    [No Abstract] [Full Text] [Related]

  • 12. Potentiation of the biphasic bradykinin response of the guinea-pig ileum.
    Hall DW, Bonta IL.
    Arch Int Pharmacodyn Ther; 1974 Feb 23; 207(2):361-72. PubMed ID: 4827420
    [No Abstract] [Full Text] [Related]

  • 13. The C-type natriuretic peptide precursor of snake brain contains highly specific inhibitors of the angiotensin-converting enzyme.
    Hayashi MA, Murbach AF, Ianzer D, Portaro FC, Prezoto BC, Fernandes BL, Silveira PF, Silva CA, Pires RS, Britto LR, Dive V, Camargo AC.
    J Neurochem; 2003 May 23; 85(4):969-77. PubMed ID: 12716428
    [Abstract] [Full Text] [Related]

  • 14. Vasoactive peptides.
    Sander GE, Huggins CG.
    Annu Rev Pharmacol; 1972 May 23; 12():227-64. PubMed ID: 4339018
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of angiotensin conversion in experimental renovascular hypertension.
    Miller ED, Samuels AI, Haber E, Barger AC.
    Science; 1972 Sep 22; 177(4054):1108-9. PubMed ID: 4341125
    [Abstract] [Full Text] [Related]

  • 16. Screening for angiotensin-induced hypertension.
    Lancet; 1971 Feb 06; 1(7693):277-8. PubMed ID: 4100023
    [No Abstract] [Full Text] [Related]

  • 17. Synthesis and properties of new bradykinin potentiating peptides.
    Tominaga M, Stewart JM.
    J Med Chem; 1975 Feb 06; 18(2):130-3. PubMed ID: 1120978
    [Abstract] [Full Text] [Related]

  • 18. Potentiation of circulatory effects of bradykinin by a factor contained in the Bothrops jararaca venom.
    Amorim DS, Ferreira SH, Manço JC, Tanaka A, Sader AA, Cardoso S.
    Cardiologia (Basel); 1967 Feb 06; 50(1):23-32. PubMed ID: 6030787
    [No Abstract] [Full Text] [Related]

  • 19. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
    Campbell DJ, Anastasopoulos F, Duncan AM, James GM, Kladis A, Briscoe TA.
    J Pharmacol Exp Ther; 1998 Nov 06; 287(2):567-77. PubMed ID: 9808682
    [Abstract] [Full Text] [Related]

  • 20. Mass spectrometric analysis of the individual variability of Bothrops jararaca venom peptide fraction. Evidence for sex-based variation among the bradykinin-potentiating peptides.
    Pimenta DC, Prezoto BC, Konno K, Melo RL, Furtado MF, Camargo AC, Serrano SM.
    Rapid Commun Mass Spectrom; 2007 Nov 06; 21(6):1034-42. PubMed ID: 17315274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.